瑞士制药巨头诺华集团周二连续第三个季度上调了年度利润预期，得益于其治疗牛皮癣和癌症的重磅药物销量的增长。

　　该公司表示，目前预计今年的核心营业利润将实现高两位数的增长，而销售额将实现低两位数的增长。

　　诺华此前曾预测，今年核心营业利润将增长将呈中到高两位数增长，而销售额将以高个位数到低两位数的比例增长。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：于健 SF069

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.